Elevance Health, Inc. (ELV) News
Follow Elevance Health, Inc. (ELV) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 74 public stories across 31 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Elevance Health Expects FY2026 Adjusted Earnings of at Least $29 per Share
EARNINGS | Nov 10, 2026, 10:13 PM UTC
M
Elevance Health Reaffirms FY2026 Benefit Expense Ratio Guidance
Elevance reaffirmed FY2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
EARNINGS | Nov 10, 2026, 09:33 PM UTC
M
Elevance expects FY2026 adjusted earnings of at least $29 per diluted share
EARNINGS | Nov 10, 2026, 09:33 PM UTC
M
Health Insurers, Hospital Shares Rally After Democratic Midterm Sweep
US health insurer and hospital operator shares rose in early trading after Democrats won the Senate and House, with the result fueling hopes for sector-friendly policy changes. Centene climbed over 8% to $73.12.
EQUITY | Nov 04, 2026, 02:58 PM UTC
M
Elevra Lithium Reports $74M Quarterly Revenue, Cuts Unit Costs 14%
Elevra reported NAL revenue of $74M for the Sep-26 quarter, up 137% quarter over quarter. Unit operating costs fell 14% to $780 per dmt sold, and cash stood at $319M at quarter-end.
EQUITY | Oct 26, 2026, 10:27 PM UTC
M
Elevra Lithium 1Q Unit Operating Cost Falls 14% to $780/Ton
Elevra Lithium reported first-quarter unit operating costs of $780 per ton, down 14% quarter on quarter.
EQUITY | Oct 26, 2026, 09:18 PM UTC
M
Elevra Lithium Reports 1Q Revenue of $74 Million
Revenue was $74 million in 1Q, compared with $31 million in 4Q FY26.
EARNINGS | Oct 26, 2026, 09:18 PM UTC
M
Elevance Health Reports Third-Quarter 2026 Revenue of $51.43B, EPS of $6.27
Elevance Health reported total revenues of $51.429B and diluted EPS of $6.27 for the quarter. Revenue grew modestly and earnings increased year over year, while total medical membership declined.
EQUITY | Oct 21, 2026, 06:21 PM UTC
M
Elevance Health Raises 2026 EPS Outlook After Third-Quarter Growth
Elevance raised its 2026 earnings-per-share outlook to at least $22 after third-quarter profit and revenue increased, offsetting lower membership.
EARNINGS | Oct 21, 2026, 11:09 AM UTC
M
Elevance Beats Third-Quarter Earnings Estimates and Raises Full-Year Guidance
Elevance Health reported a third-quarter earnings beat and lifted its full-year guidance. The supplied body is truncated before the results and revised outlook details.
EARNINGS | Oct 21, 2026, 10:23 AM UTC
M
Elevance Health Raises FY26 Adjusted Diluted EPS Guidance to At Least $29.00
EARNINGS | Oct 21, 2026, 10:13 AM UTC
M
Elevance Health 3Q Adjusted EPS $6.99
EARNINGS | Oct 21, 2026, 10:08 AM UTC
L
Elevance Health 3Q Benefit Expense Ratio 90.6%
EQUITY | Oct 21, 2026, 10:00 AM UTC
M
Elevance Health Reports Third-Quarter Net Income of $1.37 Billion
EARNINGS | Oct 21, 2026, 10:00 AM UTC
M
Elevance Health Q3 Results Due Wednesday Before Market Open
Elevance Health is scheduled to report third-quarter results Wednesday before market hours. The preview cites last quarter’s revenue of $49.83 billion, flat year over year.
EQUITY | Oct 20, 2026, 03:11 AM UTC
M
Elevance Health Expected to Report Earnings of $4.68 Per Share
An earnings preview expects Elevance Health to post earnings of $4.68 per share.
EQUITY | Oct 19, 2026, 10:02 AM UTC
M
Elevance Health Q3 Results Due October 21
Elevance Health is scheduled to report Q3 results before the market opens on October 21. Revenue is estimated at 49.29 billion USD and EPS at 4.70 USD.
EQUITY | Oct 14, 2026, 11:01 AM UTC
H
Shares of health insurance companies are trading higher the U.S. CMS awarded five- and four-star ratings to plans offered by UnitedHealth Group, Clover, and Humana among others. Also, Humana reaffirmed its FY26 adjusted EPS guidance and issued optimistic comments about FY27 and FY28.
Shares of health insurance companies are trading higher the U.S. CMS awarded five- and four-star ratings to plans offered by UnitedHealth Group, Clover, and Humana among others. Also, Humana reaffirmed its FY26 adjusted
LIVE | Oct 09, 2026, 06:42 PM UTC
H
Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To Shareholders
Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted EPS"), for the year ending December 31, 2026 ("FY 2026"). This guidance is consistent with the guidance issued in Humana’s pr
LIVE | Oct 09, 2026, 10:11 AM UTC
L
Medicare Advantage premiums expected to drop more than 16% in 2027, CMS projects
The Centers for Medicare & Medicaid Services estimates the weighted average premium for Medicare Advantage (MA) plans to fall more than 16% next year.The weighted average monthly premium across all MA plans, which includ
NEWS | Sep 29, 2026, 05:39 PM UTC
L
Americans navigate 'wild West' of health insurance options after dropping Obamacare plans
By Sriparna RoyWhen Stacy Cox, a self-employed photographer in Kanab, Utah, dropped her Obamacare health insurance plan this year, routine preventive care became a financial dilemma. Now she finds herself weighing $1,200
NEWS | Sep 25, 2026, 10:00 AM UTC
L
Elevance leads UBS health benefits survey as employers brace for higher costs
Elevance Health emerged as the highest-rated national health insurer in UBS’s annual survey of employee-benefit managers, while the three largest pharmacy-benefit managers appear well positioned to withstand a surge in c
NEWS | Sep 13, 2026, 06:01 PM UTC
H
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
Wall Street rallied on Friday after the latest consumer inflation report came in broadly in line with expectations, helping ease concerns over price pressures and supporting a rebound across risk assets.On Friday, the Do
NEWS | Sep 13, 2026, 01:11 PM UTC
M
Elevance Health reaffirms FY26 earnings guidance
Elevance Health said it is standing by its full-year 2026 adjusted earnings floor of $20.10 per diluted share ahead of investor meetings. It also kept its adjusted earnings outlook above $27.00 per share and its benefit
EARNINGS | Sep 10, 2026, 06:13 PM UTC
H
Elevance Health reaffirms FY26 GAAP and adjusted EPS guidance
EARNINGS | Sep 10, 2026, 02:11 PM UTC
H
ELV reaffirms 2026 EPS guidance; targets 12%+ 2027 growth
Management reaffirmed 2026 EPS guidance and expects at least 12% EPS growth in 2027. The company attributes the outlook to execution, favorable cost trends, disciplined investments in AI and Carelon, and strong performan
EARNINGS | Sep 10, 2026, 01:28 PM UTC
H
ELV reaffirms 2026 EPS guidance; expects 12%+ EPS growth in 2027
Elevance management reaffirmed 2026 EPS guidance and expects at least 12% EPS growth in 2027. The company cited strong execution across Medicare Advantage, Medicaid and Carelon, with AI and targeted investments supportin
EARNINGS | Sep 10, 2026, 12:59 PM UTC
L
25 dividend stocks to watch as market sentiment turns negative
Dividend-paying stocks gained renewed momentum Wednesday as investors shifted toward safety amid a slide in broader market averages.The blue-chip Dow Jones Industrial Average TVC:DJI dropped to a new one-month low while
ENERGY | Sep 09, 2026, 04:51 PM UTC
L
Elevra Lithium announces pre-feasibility study results for NAL expansion
Elevra Lithium Limited says it has published results of a Pre-Feasibility Study for the staged North American Lithium (NAL) Brownfield Expansion, with details described as in Q…
EQUITY | Sep 08, 2026, 08:37 PM UTC
M
ELV: Elevra expansion projects fully funded for capacity growth
Elevra says its NAL and Moblan expansion projects are fully funded, targeting significant capacity growth, and cites North America’s largest hard-rock lithium resource base and major producer operations.
EQUITY | Sep 07, 2026, 10:46 PM UTC
M
Elevra Lithium estimates life-of-mine AISC at C$918/ton post-expansion
Elevra Lithium estimates life-of-mine AISC post-expansion at C$918/ton.
EQUITY | Sep 06, 2026, 10:32 PM UTC
L
Elevra Lithium PFS confirms expansion capex of C$366 million
Elevra Lithium’s PFS confirms expansion capital expenditure of C$366 million.
EQUITY | Sep 06, 2026, 10:31 PM UTC
M
Elevra Lithium expansion targets 373,000-ton average annual output
Elevra Lithium says its North American expansion is set to lift average annual output to 373,000 tons.
EQUITY | Sep 06, 2026, 10:29 PM UTC
L
Macquarie cuts Elevra Lithium target price 5.7% to A$12.50
Macquarie cut Elevra Lithium’s target price by 5.7% to A$12.50 a share.
EQUITY | Aug 31, 2026, 12:07 AM UTC
H
Elevra Lithium targets FY27 capex of $120M–$140M
Elevra Lithium says FY27 capital expenditures will be $120 million to $140 million.
EARNINGS | Aug 28, 2026, 01:30 AM UTC
H
ELV: Strong revenue growth, merger synergies, and fully funded expansion drive positive outlook
ELV: Strong revenue growth, merger synergies, and fully funded expansion drive positive outlook
EARNINGS | Aug 27, 2026, 10:13 PM UTC
M
ELV reports first full-year profit
ELV says it delivered its first full-year profit, attributing results to higher lithium prices, merger synergies, and robust cash flows.
MNA | Aug 27, 2026, 10:11 PM UTC
L
Elevra Lithium will not pay a final dividend
Elevra Lithium says it will not pay a final dividend.
EQUITY | Aug 27, 2026, 10:00 PM UTC
L
Elevra Lithium FY revenue A$201.7 million, up 39%
Elevra Lithium reported FY revenue of A$201.7 million, up 39% year over year.
EQUITY | Aug 27, 2026, 10:00 PM UTC
L
Elevra Lithium reports FY net profit of A$43.1 million
Elevra Lithium said its FY net profit was A$43.1 million.
EQUITY | Aug 27, 2026, 10:00 PM UTC
H
ELV faces EPS decline in 2026, per Argus
Hammerstone MarketTalk says ELV is facing an EPS decline in 2026 at Argus, but provides no EPS level, magnitude, or catalyst in the alert.
EARNINGS | Aug 21, 2026, 12:57 PM UTC
L
CDW, Elevance, Omnicom hit highs
CDW, Elevance Health and Omnicom are hitting highs, with no catalyst or magnitude supplied in the feed.
EQUITY | Aug 19, 2026, 05:43 PM UTC
L
HUM CI UNH ELV The Trump administration plans to end a subsidy program that helped hold down premiums for Medicare drug plans, a move that c
HUM CI UNH ELV The Trump administration plans to end a subsidy program that helped hold down premiums for Medicare drug plans, a move that could leave many seniors facing higher rates for their prescription coverage next
GEOPOLITICS | Jul 28, 2026, 08:00 PM UTC
L
Underperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - TSLA -8.75%, AMZN - 0.16%, NCLH +0.36%, CVNA +0.56%, DASH +
Underperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - TSLA -8.75%, AMZN - 0.16%, NCLH +0.36%, CVNA +0.56%, DASH +0.64% Consumer Staples (XLP) - DG -2.81%, EL -2.72%, KR -2.15%, DLTR -2.06%, GIS
RATES | Jul 23, 2026, 04:00 PM UTC
L
ELV Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 Link To Filing
ELV Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 Link To Filing
EQUITY | Jul 17, 2026, 06:01 PM UTC
H
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
UnitedHealth Group (NYSE: UNH ) surged about 9% in premarket trading Thursday after raising its full-year earnings guidance, despite reporting a loss of 965,000 Medicare Advantage members since the end of 2025. The move
RATES | Jul 16, 2026, 05:24 PM UTC
H
Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel It
Starting in December 2026, millions of Medicaid enrollees will have to prove they still qualify twice as often as they do today, and the Urban Institute estimates the change could push 2 to 3.1 million people out of the
EARNINGS | Jul 16, 2026, 01:24 PM UTC
L
ELV PT raised from $399 to $455, maintains Buy @ GUGG
ELV PT raised from $399 to $455, maintains Buy @ GUGG
EQUITY | Jul 16, 2026, 12:56 PM UTC
H
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported upbeat second-quarter results and raised its full-year guidance. Adjusted earnings came in at $7.45 per share, beating the analyst consensus estimate of $6.21. Reve
EARNINGS | Jul 16, 2026, 12:17 PM UTC
H
Sector Update: Healthcare Stocks Advance Late Afternoon
() -- Healthcare stocks rose late Wednesday afternoon, with the NYSE Healthcare Index adding 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.1%. The iShares Biotechnology ETF (IBB) added 0
EARNINGS | Jul 15, 2026, 07:47 PM UTC
H
Top Midday Decliners
() -- Pentair (PNR) reported preliminary Q2 results below market estimates and lowered its full-year outlook amid headwinds related to its pool segment. Pentair CFO Nick Brazis' unexpected departure, just four months aft
EARNINGS | Jul 15, 2026, 06:40 PM UTC
L
Underperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - ORLY -3.68%, YUM -3.53%, CMG -3.12%, AZO -2.27%, GPC - 2.08
Underperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - ORLY -3.68%, YUM -3.53%, CMG -3.12%, AZO -2.27%, GPC - 2.08% Consumer Staples (XLP) - MKC -3.39%, CASY -3.31%, KR -3.23%, SYY -2.79%, BG -
RATES | Jul 15, 2026, 06:23 PM UTC
H
Sector Update: Healthcare Stocks Advance in Afternoon Trading
() -- Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index adding 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.3%. The iShares Biotechnology ETF (IBB) added 0.3%.
EARNINGS | Jul 15, 2026, 05:41 PM UTC
H
Top Midday Stories: PayPal Reportedly Gets Acquisition Offer From Stripe, Advent; ASML Misses Q2 EPS, Sales Estimates, Lifts Outlook
() -- All three major US stock indexes were up in late-morning trading Wednesday, as technology stocks led the way up and additional inflation data showed further cooling. The US Producer Price Index fell by 0.3% in June
MACRO | Jul 15, 2026, 03:50 PM UTC
H
Elevance Second-Quarter Membership Declines Overshadow Full-Year Earnings Outlook Raise
() -- Elevance Health (ELV) reported sequential and annual declines in its second-quarter memberships, although the health insurer lifted its full-year earnings outlook and recorded an unexpected year-over-year revenue i
EARNINGS | Jul 15, 2026, 03:43 PM UTC
H
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported second-quarter results that topped Wall Street estimates and raised its full-year adjusted earnings and operating cash flow guidance, supported by higher premium yi
EARNINGS | Jul 15, 2026, 02:22 PM UTC
L
ELV Elevance health exec notes Co is seeing moderately lower Surgery trends in medicare and obamacare plans- conf call
ELV Elevance health exec notes Co is seeing moderately lower Surgery trends in medicare and obamacare plans- conf call
RATES | Jul 15, 2026, 01:27 PM UTC
H
Sector Update: Healthcare Stocks Decline Premarket Wednesday
() -- Healthcare stocks were declining premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.6% and the iShares Biotechnology ETF (IBB) 0.1% lower. Elevance Health (ELV) shares were d
EARNINGS | Jul 15, 2026, 01:16 PM UTC
H
Sector Update: Healthcare
() -- Healthcare stocks were declining premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4% and the iShares Biotechnology ETF (IBB) 0.1% lower. Elevance Health (ELV) shares were d
EARNINGS | Jul 15, 2026, 12:59 PM UTC
H
Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Nasdaq 100 futures gaining around 100 points on Wednesday. Shares of Phoenix Education Partners Inc (NYSE: PXED ) fell sharply in pre-market trading after the
EARNINGS | Jul 15, 2026, 12:02 PM UTC